Calcium Carbonate to Augment Labor Contractions

Part of paid clinical trials in New York, New York.

Sponsor
Weill Medical College of Cornell University
Study ID
NCT06580782
Phase
PHASE4
Status
Recruiting
Apply to this trial

Conditions

  • Labor Augmentation
  • Labor Dystocia
  • Labor Induction

Eligibility Criteria

Sex
FEMALE
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Calcium Carbonate 500 MG — DRUG
    Calcium Carbonate 500mg, orally, every 4 hours.
  • Standard Dose Synthetic Pitocin — DRUG
    The participant will receive thestandard-dose synthetic oxytocin for labor induction or augmentation.

Study Details

The investigators think that calcium carbonate can act as an assistive medication to improve contractions during labor.

Key Dates

Start date
Nov 18, 2024
Status verified
Oct 2025
Primary completion
Dec 31, 2025
Completion
Dec 31, 2025

Study Design

Enrollment
60 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Active Comparator: Pitocin
    Control group will receive only the standard-dose synthetic oxytocin (Pitocin) alone for labor induction or augmentation.
  • Experimental: Calcium Carbonate with Pitocin
    Participants will start an oral calcium carbonate regimen at the same time as initiating synthetic oxytocin (Pitocin) infusion.

Primary Outcome Measure

Number of Participants Consented [ Time Frame: Day 0 ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Weill Cornell MedicineNew YorkNew York10065
Ester Sanchez, BSN
[email protected]
212-746-2106
Moeun Son, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in New York, NY

By research site
Weill Cornell Medicine· New York, NY

Related Studies